EClinicalMedicine 润色咨询

EClinicalMedicine

出版年份:暂无数据 年文章数:800 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2195328, encodeId=27262195328a4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:无投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daa79231007, createdName=ms3000001661232973, createdTime=Mon Mar 25 21:56:28 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊,我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine,预计自己的文章在10-30之间,这种接收概率大吗?这个杂志2023预计影响因子有多少,是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2187957, encodeId=9517218e95705, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:编辑很nice,也很细心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de166462153, createdName=ms9000001999156742, createdTime=Sun Feb 18 14:05:11 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157837, encodeId=5318215e8377a, content=2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93bb8315605, createdName=ms1000000667415119, createdTime=Fri Sep 15 14:42:32 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0<br>偏重的研究方向:人工智能<br>经验分享:真的是超快……大修回去几天就回来了,小修下午回去,晚上就接收了,全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右,高被引清一色的COVID-19论文,随着发文增加和疫情热度降低,IF会走低,2022实时IF已经只有10左右了,低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来,状态变成revise,4个审稿人,一共31条意见,还要求补做很多实验,之前的实验也要重新修正,编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor,当天晚上under review 2.15 二审意见回来,审稿人均无意见,编辑让按杂志社要求更改文章格式和排版,给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收,全程约两个半月,特来分享投稿经历,希望给到需要的帮助,祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区,为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2107107, encodeId=c294210e107e9, content=JCR一区,中科院三区,6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495623515, createdName=ms4000001058281214, createdTime=Thu Dec 22 22:55:15 CST 2022, time=2022-12-22, status=1, ipAttribution=湖北省)]
    2024-03-25 ms3000001661232973 来自广东省

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:无投稿经验

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2195328, encodeId=27262195328a4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:无投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daa79231007, createdName=ms3000001661232973, createdTime=Mon Mar 25 21:56:28 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊,我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine,预计自己的文章在10-30之间,这种接收概率大吗?这个杂志2023预计影响因子有多少,是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2187957, encodeId=9517218e95705, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:编辑很nice,也很细心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de166462153, createdName=ms9000001999156742, createdTime=Sun Feb 18 14:05:11 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157837, encodeId=5318215e8377a, content=2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93bb8315605, createdName=ms1000000667415119, createdTime=Fri Sep 15 14:42:32 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0<br>偏重的研究方向:人工智能<br>经验分享:真的是超快……大修回去几天就回来了,小修下午回去,晚上就接收了,全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右,高被引清一色的COVID-19论文,随着发文增加和疫情热度降低,IF会走低,2022实时IF已经只有10左右了,低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来,状态变成revise,4个审稿人,一共31条意见,还要求补做很多实验,之前的实验也要重新修正,编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor,当天晚上under review 2.15 二审意见回来,审稿人均无意见,编辑让按杂志社要求更改文章格式和排版,给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收,全程约两个半月,特来分享投稿经历,希望给到需要的帮助,祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区,为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2107107, encodeId=c294210e107e9, content=JCR一区,中科院三区,6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495623515, createdName=ms4000001058281214, createdTime=Thu Dec 22 22:55:15 CST 2022, time=2022-12-22, status=1, ipAttribution=湖北省)]
    2022-08-10 ms7000001962210336

    请问submitted to journal一般多久啊,我都五天了还是没变😭😭

    8

    展开8条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2195328, encodeId=27262195328a4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:无投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daa79231007, createdName=ms3000001661232973, createdTime=Mon Mar 25 21:56:28 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊,我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine,预计自己的文章在10-30之间,这种接收概率大吗?这个杂志2023预计影响因子有多少,是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2187957, encodeId=9517218e95705, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:编辑很nice,也很细心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de166462153, createdName=ms9000001999156742, createdTime=Sun Feb 18 14:05:11 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157837, encodeId=5318215e8377a, content=2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93bb8315605, createdName=ms1000000667415119, createdTime=Fri Sep 15 14:42:32 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0<br>偏重的研究方向:人工智能<br>经验分享:真的是超快……大修回去几天就回来了,小修下午回去,晚上就接收了,全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右,高被引清一色的COVID-19论文,随着发文增加和疫情热度降低,IF会走低,2022实时IF已经只有10左右了,低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来,状态变成revise,4个审稿人,一共31条意见,还要求补做很多实验,之前的实验也要重新修正,编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor,当天晚上under review 2.15 二审意见回来,审稿人均无意见,编辑让按杂志社要求更改文章格式和排版,给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收,全程约两个半月,特来分享投稿经历,希望给到需要的帮助,祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区,为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2107107, encodeId=c294210e107e9, content=JCR一区,中科院三区,6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495623515, createdName=ms4000001058281214, createdTime=Thu Dec 22 22:55:15 CST 2022, time=2022-12-22, status=1, ipAttribution=湖北省)]
    2024-02-29 148ad189m02(暂无昵称) 来自北京

    投了lancet oncology编辑建议转投eclinicalmedicine,预计自己的文章在10-30之间,这种接收概率大吗?这个杂志2023预计影响因子有多少,是不是会降低啊

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2195328, encodeId=27262195328a4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:无投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daa79231007, createdName=ms3000001661232973, createdTime=Mon Mar 25 21:56:28 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊,我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine,预计自己的文章在10-30之间,这种接收概率大吗?这个杂志2023预计影响因子有多少,是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2187957, encodeId=9517218e95705, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:编辑很nice,也很细心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de166462153, createdName=ms9000001999156742, createdTime=Sun Feb 18 14:05:11 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157837, encodeId=5318215e8377a, content=2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93bb8315605, createdName=ms1000000667415119, createdTime=Fri Sep 15 14:42:32 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0<br>偏重的研究方向:人工智能<br>经验分享:真的是超快……大修回去几天就回来了,小修下午回去,晚上就接收了,全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右,高被引清一色的COVID-19论文,随着发文增加和疫情热度降低,IF会走低,2022实时IF已经只有10左右了,低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来,状态变成revise,4个审稿人,一共31条意见,还要求补做很多实验,之前的实验也要重新修正,编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor,当天晚上under review 2.15 二审意见回来,审稿人均无意见,编辑让按杂志社要求更改文章格式和排版,给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收,全程约两个半月,特来分享投稿经历,希望给到需要的帮助,祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区,为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2107107, encodeId=c294210e107e9, content=JCR一区,中科院三区,6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495623515, createdName=ms4000001058281214, createdTime=Thu Dec 22 22:55:15 CST 2022, time=2022-12-22, status=1, ipAttribution=湖北省)]
    2024-02-18 ms9000001999156742 来自上海

    审稿速度:2.0 | 投稿命中率:95.0
    偏重的研究方向:肿瘤
    经验分享:编辑很nice,也很细心

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2195328, encodeId=27262195328a4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:无投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daa79231007, createdName=ms3000001661232973, createdTime=Mon Mar 25 21:56:28 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊,我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine,预计自己的文章在10-30之间,这种接收概率大吗?这个杂志2023预计影响因子有多少,是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2187957, encodeId=9517218e95705, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:编辑很nice,也很细心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de166462153, createdName=ms9000001999156742, createdTime=Sun Feb 18 14:05:11 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157837, encodeId=5318215e8377a, content=2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93bb8315605, createdName=ms1000000667415119, createdTime=Fri Sep 15 14:42:32 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0<br>偏重的研究方向:人工智能<br>经验分享:真的是超快……大修回去几天就回来了,小修下午回去,晚上就接收了,全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右,高被引清一色的COVID-19论文,随着发文增加和疫情热度降低,IF会走低,2022实时IF已经只有10左右了,低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来,状态变成revise,4个审稿人,一共31条意见,还要求补做很多实验,之前的实验也要重新修正,编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor,当天晚上under review 2.15 二审意见回来,审稿人均无意见,编辑让按杂志社要求更改文章格式和排版,给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收,全程约两个半月,特来分享投稿经历,希望给到需要的帮助,祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区,为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2107107, encodeId=c294210e107e9, content=JCR一区,中科院三区,6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495623515, createdName=ms4000001058281214, createdTime=Thu Dec 22 22:55:15 CST 2022, time=2022-12-22, status=1, ipAttribution=湖北省)]
    2023-09-15 ms1000000667415119 来自北京

    2

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2195328, encodeId=27262195328a4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:无投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daa79231007, createdName=ms3000001661232973, createdTime=Mon Mar 25 21:56:28 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊,我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine,预计自己的文章在10-30之间,这种接收概率大吗?这个杂志2023预计影响因子有多少,是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2187957, encodeId=9517218e95705, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:编辑很nice,也很细心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de166462153, createdName=ms9000001999156742, createdTime=Sun Feb 18 14:05:11 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157837, encodeId=5318215e8377a, content=2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93bb8315605, createdName=ms1000000667415119, createdTime=Fri Sep 15 14:42:32 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0<br>偏重的研究方向:人工智能<br>经验分享:真的是超快……大修回去几天就回来了,小修下午回去,晚上就接收了,全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右,高被引清一色的COVID-19论文,随着发文增加和疫情热度降低,IF会走低,2022实时IF已经只有10左右了,低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来,状态变成revise,4个审稿人,一共31条意见,还要求补做很多实验,之前的实验也要重新修正,编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor,当天晚上under review 2.15 二审意见回来,审稿人均无意见,编辑让按杂志社要求更改文章格式和排版,给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收,全程约两个半月,特来分享投稿经历,希望给到需要的帮助,祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区,为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2107107, encodeId=c294210e107e9, content=JCR一区,中科院三区,6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495623515, createdName=ms4000001058281214, createdTime=Thu Dec 22 22:55:15 CST 2022, time=2022-12-22, status=1, ipAttribution=湖北省)]
    2022-08-09 121e52e6m31(暂无昵称)

    审稿速度:2.0
    偏重的研究方向:人工智能
    经验分享:真的是超快……大修回去几天就回来了,小修下午回去,晚上就接收了,全程2月……好评

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2195328, encodeId=27262195328a4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:无投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daa79231007, createdName=ms3000001661232973, createdTime=Mon Mar 25 21:56:28 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊,我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine,预计自己的文章在10-30之间,这种接收概率大吗?这个杂志2023预计影响因子有多少,是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2187957, encodeId=9517218e95705, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:编辑很nice,也很细心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de166462153, createdName=ms9000001999156742, createdTime=Sun Feb 18 14:05:11 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157837, encodeId=5318215e8377a, content=2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93bb8315605, createdName=ms1000000667415119, createdTime=Fri Sep 15 14:42:32 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0<br>偏重的研究方向:人工智能<br>经验分享:真的是超快……大修回去几天就回来了,小修下午回去,晚上就接收了,全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右,高被引清一色的COVID-19论文,随着发文增加和疫情热度降低,IF会走低,2022实时IF已经只有10左右了,低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来,状态变成revise,4个审稿人,一共31条意见,还要求补做很多实验,之前的实验也要重新修正,编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor,当天晚上under review 2.15 二审意见回来,审稿人均无意见,编辑让按杂志社要求更改文章格式和排版,给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收,全程约两个半月,特来分享投稿经历,希望给到需要的帮助,祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区,为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2107107, encodeId=c294210e107e9, content=JCR一区,中科院三区,6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495623515, createdName=ms4000001058281214, createdTime=Thu Dec 22 22:55:15 CST 2022, time=2022-12-22, status=1, ipAttribution=湖北省)]
    2022-06-07 HONGGE

    第一个IF确实是15左右,高被引清一色的COVID-19论文,随着发文增加和疫情热度降低,IF会走低,2022实时IF已经只有10左右了,低于2021IF是必然

    9

    展开9条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2195328, encodeId=27262195328a4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:无投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daa79231007, createdName=ms3000001661232973, createdTime=Mon Mar 25 21:56:28 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊,我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine,预计自己的文章在10-30之间,这种接收概率大吗?这个杂志2023预计影响因子有多少,是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2187957, encodeId=9517218e95705, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:编辑很nice,也很细心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de166462153, createdName=ms9000001999156742, createdTime=Sun Feb 18 14:05:11 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157837, encodeId=5318215e8377a, content=2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93bb8315605, createdName=ms1000000667415119, createdTime=Fri Sep 15 14:42:32 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0<br>偏重的研究方向:人工智能<br>经验分享:真的是超快……大修回去几天就回来了,小修下午回去,晚上就接收了,全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右,高被引清一色的COVID-19论文,随着发文增加和疫情热度降低,IF会走低,2022实时IF已经只有10左右了,低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来,状态变成revise,4个审稿人,一共31条意见,还要求补做很多实验,之前的实验也要重新修正,编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor,当天晚上under review 2.15 二审意见回来,审稿人均无意见,编辑让按杂志社要求更改文章格式和排版,给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收,全程约两个半月,特来分享投稿经历,希望给到需要的帮助,祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区,为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2107107, encodeId=c294210e107e9, content=JCR一区,中科院三区,6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495623515, createdName=ms4000001058281214, createdTime=Thu Dec 22 22:55:15 CST 2022, time=2022-12-22, status=1, ipAttribution=湖北省)]
    2023-03-05 只想躺平的小医生 来自广东省

    12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来,状态变成revise,4个审稿人,一共31条意见,还要求补做很多实验,之前的实验也要重新修正,编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor,当天晚上under review 2.15 二审意见回来,审稿人均无意见,编辑让按杂志社要求更改文章格式和排版,给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收,全程约两个半月,特来分享投稿经历,希望给到需要的帮助,祝大家投稿都能有好的结果

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2195328, encodeId=27262195328a4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:无投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daa79231007, createdName=ms3000001661232973, createdTime=Mon Mar 25 21:56:28 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊,我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine,预计自己的文章在10-30之间,这种接收概率大吗?这个杂志2023预计影响因子有多少,是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2187957, encodeId=9517218e95705, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:编辑很nice,也很细心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de166462153, createdName=ms9000001999156742, createdTime=Sun Feb 18 14:05:11 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157837, encodeId=5318215e8377a, content=2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93bb8315605, createdName=ms1000000667415119, createdTime=Fri Sep 15 14:42:32 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0<br>偏重的研究方向:人工智能<br>经验分享:真的是超快……大修回去几天就回来了,小修下午回去,晚上就接收了,全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右,高被引清一色的COVID-19论文,随着发文增加和疫情热度降低,IF会走低,2022实时IF已经只有10左右了,低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来,状态变成revise,4个审稿人,一共31条意见,还要求补做很多实验,之前的实验也要重新修正,编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor,当天晚上under review 2.15 二审意见回来,审稿人均无意见,编辑让按杂志社要求更改文章格式和排版,给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收,全程约两个半月,特来分享投稿经历,希望给到需要的帮助,祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区,为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2107107, encodeId=c294210e107e9, content=JCR一区,中科院三区,6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495623515, createdName=ms4000001058281214, createdTime=Thu Dec 22 22:55:15 CST 2022, time=2022-12-22, status=1, ipAttribution=湖北省)]
    2022-12-22 dangjunsy 来自辽宁省

    该杂志2022年中科院分区为3区,为啥啊。哪位高手能解释下吗

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2195328, encodeId=27262195328a4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:无投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daa79231007, createdName=ms3000001661232973, createdTime=Mon Mar 25 21:56:28 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊,我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine,预计自己的文章在10-30之间,这种接收概率大吗?这个杂志2023预计影响因子有多少,是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2187957, encodeId=9517218e95705, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:编辑很nice,也很细心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de166462153, createdName=ms9000001999156742, createdTime=Sun Feb 18 14:05:11 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157837, encodeId=5318215e8377a, content=2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93bb8315605, createdName=ms1000000667415119, createdTime=Fri Sep 15 14:42:32 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0<br>偏重的研究方向:人工智能<br>经验分享:真的是超快……大修回去几天就回来了,小修下午回去,晚上就接收了,全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右,高被引清一色的COVID-19论文,随着发文增加和疫情热度降低,IF会走低,2022实时IF已经只有10左右了,低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来,状态变成revise,4个审稿人,一共31条意见,还要求补做很多实验,之前的实验也要重新修正,编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor,当天晚上under review 2.15 二审意见回来,审稿人均无意见,编辑让按杂志社要求更改文章格式和排版,给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收,全程约两个半月,特来分享投稿经历,希望给到需要的帮助,祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区,为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2107107, encodeId=c294210e107e9, content=JCR一区,中科院三区,6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495623515, createdName=ms4000001058281214, createdTime=Thu Dec 22 22:55:15 CST 2022, time=2022-12-22, status=1, ipAttribution=湖北省)]
    2022-12-22 ms4000001058281214 来自湖北省

    JCR一区,中科院三区,6

    0

共116条页码: 1/12页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分